Important Information for Nominees

If you purchased the preferred or common stock of Allergan for the beneficial interest of any person or entity other than yourself, you must, WITHIN TEN (10) DAYS OF YOUR RECEIPT OF THE POSTCARD NOTICE, either: (a) request from the Notice Administrator sufficient copies of the Postcard Notice to forward to all such beneficial owners and within seven (7) calendar days of receipt of those notices, forward them to all such beneficial owners; (b) request an electronic copy of the Summary Notice from the Notice Administrator and, within seven (7) calendar days of receipt of the electronic Summary Notice, email the Summary Notice to beneficial owners; or (c) provide a list of the names and the last known addresses of each person or entity for whom or which you purchased such preferred or common stock during the relevant period to the Notice Administrator.

If you select option (a) or (b) above, you must send a statement to the Notice Administrator confirming that the mailing or emailing was made, and you must retain your mailing or emailing records for use in connection with any further notices that may be provided in this Action. If you select option (c), the Notice Administrator will send a copy of the Postcard Notice to the beneficial owners.

If you are providing a list of names and addresses to the Notice Administrator:

1. Compile a list of names, mailing addresses, and, if available, email addresses of the beneficial owners who purchased Allergan preferred or common stock between January 30, 2017 and December 19, 2018.
2. Prepare the list in Microsoft Excel format. A preformatted spreadsheet for your use can be found by clicking here.
3. Then you must do one of the following:
   1. Upload the spreadsheet here (preferred);
   2. Email the spreadsheet to: info@AllerganSecuritiesLitigation.com.
   3. Burn the Microsoft Excel file(s) to a CD or DVD and mail the CD or DVD to: Allergan PLC Securities Litigation, c/o Analytics Consulting LLC, P.O. Box 2009, Chanhassen, MN 55317-2009.